National HealthCare Corporation NHC
227.36
5.76
2.60%
as of 25 Sep
- Market cap
- $3.5B
- P/E
- 25.2×
Follow NHC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
23.43 | 20.04 | 17.69 | 18.58 |
+8 more quarters Free account |
P/S ratio |
2.12 | 1.63 | 1.40 | 1.25 | |
P/FCF ratio |
22.53 | 14.74 | 14.27 | 12.63 | |
P/Operating CF |
76.29 | 39.69 | 126.20 | 28.42 | |
P/B ratio |
2.93 | 2.26 | 1.97 | 1.78 | |
Price to Tangible BV |
3.52 | 2.74 | 2.40 | 2.17 | |
EV/Sales |
1.99 | 1.47 | 1.24 | 1.07 | |
EV/EBITDA |
16.32 | 12.79 | 10.88 | 9.53 | |
EV/Operating CF |
16.46 | 10.77 | 10.18 | 8.88 | |
EV/FCF |
21.21 | 13.32 | 12.68 | 10.79 | |
Quick Ratio |
1.71 | 1.79 | 1.77 | 1.70 | |
Current Ratio |
1.86 | 1.86 | 1.82 | 1.75 | |
Net Debt/EBITDA |
(4.42) | (7.10) | (6.72) | (6.60) | |
Debt/Assets |
0.00% | 0.00% | 0.49% | 4.65% | |
Debt/Equity |
0.00 | 0.00 | 0.01 | 0.07 | |
Asset Turnover |
1.01 | 0.99 | 1.00 | 0.96 | |
Operating CF/Net income |
1.07 | 1.74 | 0.68 | 1.69 | |
Capex/Depreciation |
(1.12) | (0.83) | (0.88) | (0.87) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
82.44% | 85.46% | 85.23% | 86.18% | |
Intangible Assets out of Total Assets |
0.12 | 0.12 | 0.12 | 0.12 | |
Share Based Compensation of Revenue |
0.49% | 0.34% | 0.23% | 0.32% | |
Graham Net Nets |
0.01 | 0.02 | 0.00 | (0.01) | |
Graham Number |
121.07 | 112.48 | 110.05 | 100.28 | |
Earnings Yield |
4.27% | 4.99% | 5.65% | 5.38% | |
Free Cash Flow Yield |
4.44% | 6.78% | 7.01% | 7.92% | |
Revenue per Share |
26.13 | 24.57 | 24.98 | 24.71 | |
Operating CF per Share |
2.77 | 4.02 | 1.09 | 4.28 | |
Capex per Share |
(0.80) | (0.62) | (0.67) | (0.63) | |
Free Cash Flow per Share |
1.97 | 3.40 | 0.41 | 3.65 | |
Cash per Share |
17.02 | 20.05 | 19.98 | 22.43 | |
Shareholders Equity per Share |
72.23 | 70.56 | 69.45 | 68.34 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
72.23 | 70.56 | 69.45 | 68.34 | |
Free Cash Flow |
30.74 | 52.89 | 6.41 | 56.49 | |
Working Capital |
203.49 | 214.75 | 208.19 | 211.16 | |
Capital Expenditures |
(12.53) | (9.64) | (10.40) | (9.71) | |
Net Current Asset Value |
30.73 | 38.10 | 9.92 | (20.40) | |
EV/EBIT |
21.48 | 17.28 | 14.69 | 12.95 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
9.88% | 9.39% | 6.43% | 10.25% | |
Price to Operating Income |
22.82 | 19.12 | 16.53 | 15.16 | |
| Other line items | |||||
Average Receivables |
139.88 | 139.74 | 137.16 | 130.62 | |
Average Payables |
21.51 | 21.51 | 24.13 | 22.65 | |
Average Inventory |
8.21 | 8.61 | 8.42 | 7.84 | |
Average Assets |
1,549.58 | 1,536.46 | 1,525.42 | 1,567.42 | |
Average Common Equity |
1,076.72 | 1,052.30 | 1,028.84 | 1,022.51 |
Columns are period end dates